UK markets open in 1 hour 34 minutes
NIKKEI 225
28,880.17 +333.19 (+1.17%) HANG SENG
20,139.06 -36.56 (-0.18%) CRUDE OIL
91.19 -0.90 (-0.98%) GOLD FUTURES
1,809.40 -6.10 (-0.34%) DOW
33,761.05 +424.35 (+1.27%) BTC-GBP
20,512.30 +134.12 (+0.66%)
Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
At close: 05:29PM CEST
| Previous close | 234.90 |
| Open | 234.90 |
| Bid | 234.30 x 0 |
| Ask | 234.80 x 0 |
| Day's range | 232.70 - 235.50 |
| 52-week range | 166.50 - 245.40 |
| Volume | |
| Avg. volume | 659,262 |
| Market cap | 69.007B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 27.77 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Has Swedish Orphan Biovitrum (BIOVF) Outpaced Other Medical Stocks This Year?
Here is how Swedish Orphan Biovitrum (BIOVF) and EDAP TMS S.A. (EDAP) have performed compared to their sector so far this year.
- Zacks
Swedish Orphan Biovitrum (BIOVF) Stock Jumps 5.3%: Will It Continue to Soar?
Swedish Orphan Biovitrum (BIOVF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks
Apellis (APLS) Hit By Wider-Than-Expected Q1 Loss, Revenues Top
Apellis' (APLS) earnings missed estimates in the first quarter of 2022, while revenues surpassed expectations.
© 2022 Yahoo. All rights reserved.
